Drug susceptibility testing for optimizing tuberculosis treatment.
SourceCurrent Pharmaceutical Design, 17, 27, (2011), pp. 2863-2874
Article / Letter to editor
Display more detailsDisplay less details
Current Pharmaceutical Design
SubjectN4i 1: Pathogenesis and modulation of inflammation; N4i 1: Pathogenesis and modulation of inflammation NCMLS 1: Infection and autoimmunity; N4i 3: Poverty-related infectious diseases
Upload full text